In recent years, Cloud computing has been developed and become the foundation of a wide range of applications. It allows users to access a catalog of standardized services and respond to their business needs flexibly and adaptively, in the event of unforeseen demands, paying solely for the consumption they have made. Task scheduling problem is considered one of the most critical cloud computing challenges. The problem refers to how to reasonably order and allocate the applications tasks provided by the users to be executed on virtual machines. Furthermore, the quality of scheduling performance has a direct effect on customer satisfaction. The task scheduling problem in cloud computing must be more accurately described in order to improve scheduling performance. In this paper, a multi-objective task scheduling algorithm is proposed based on the decision tree in a heterogenous environment. We introduce a new Task Scheduling-Decision Tree (TS-DT) algorithm for allocating and executing an application's task. To evaluate the performance of the proposed TS-DT algorithm, a comparative study was conducted among the existing algorithms; Heterogeneous Earliest Finish Time (HEFT), Technique for Order of Preference by Similarity to Ideal Solution that incorporates the Entropy Weight Method (TOPSIS-EWM), and combining Q-Learning with the Heterogeneous Earliest Finish Time (QL-HEFT). Our results show that the proposed TS-DT algorithm outperforms the existing HEFT, TOPSIS-EWM, and QL-HEFT algorithms by reducing makespan by 5.21%, 2.54%, and 3.32%, respectively, improving resource utilization by 4.69%, 6.81%, and 8.27%, respectively, and improving load balancing by 33.36%, 19.69%, and 59.06%, respectively in average.
In Egypt, pneumococcal vaccines have not yet been introduced as being compulsory. Identification of the circulating serotypes in Egypt is mandatory to determine whether or not the pneumococcal vaccines will be beneficial. The current study aims to identify the serotypes, vaccine coverage, and antimicrobial resistance of Streptococcus pneumoniae colonizing the nasopharynx of Egyptian children younger than 5 years old. The study was conducted in two successive winter seasons (December 2012-February 2013 and December 2013-February 2014). Two hundred children were enrolled, aged from 6 months to 5 years, excluding those with fever, signs of infection, history of antibiotic intake, and hospitalization in the preceding month. Nasopharyngeal (NP) secretions were collected, subjected to culture, and underwent antibiotic susceptibility testing if positive for pneumococci. Real-time polymerase chain reaction (PCR) and serotyping by sequential multiplex PCR for positive cases were included as well. Streptococcus pneumoniae was isolated from 62 subjects. All isolates were sensitive to vancomycin and levofloxacin, but the majority showed resistance to multiple antibiotics. PCR was positive for pneumococci in 113 subjects (56.5%). The most commonly detected serotypes (st) were 6A6B6C (n = 21, 20.8%), 19F (n = 19, 18.8%), 1 (n = 11, 10.9%), 34 (n = 8, 7.9%), and 19A (n = 6, 5.9%). The theoretical coverage of the PCV13 vaccine for the detected serotypes was 72.4%, while that of PCV10 was 65.5%. Based on these percentages, we recommend including pneumococcal conjugate vaccines in the Egyptian national vaccination program.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.